newsfilter
← Latest News
PR Newswire·

Medivir has completed a successful pre-IND meeting with the FDA

STOCKHOLM, Dec. 12, 2022 /PRNewswire/ -- Medivir AB (NASDAQ:MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today